Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Frontiers in Oncology
|
March 21, 2022
Editorial: Quantitative Imaging for Clinical Decisions
Nandita Maria deSouza, Daniela Elena Oprea-Lager, Laure S Fournier
European Journal of Nuclear Medicine and Molecular Imaging
|
January 27, 2024
The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today
Daniela-Elena Oprea-Lager, Steven MacLennan, Rudi Dierckx, et al.
European Radiology
|
October 31, 2025
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology
|
May 23, 2025
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
Frontiers in Oncology
|
January 27, 2022
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper
Laure Fournier, Lioe-Fee de Geus-Oei, Daniele Regge, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 21, 2023
[<sup>18</sup>F]DCFPyL PET/CT versus [<sup>18</sup>F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study
Daniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, et al.
European Urology
|
September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
Daniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
The Lancet. Oncology
|
August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Frontiers in Oncology
|
March 21, 2022
Editorial: Quantitative Imaging for Clinical Decisions
Nandita Maria deSouza, Daniela Elena Oprea-Lager, Laure S Fournier
European Journal of Nuclear Medicine and Molecular Imaging
|
January 27, 2024
The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today
Daniela-Elena Oprea-Lager, Steven MacLennan, Rudi Dierckx, et al.
European Radiology
|
October 31, 2025
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology
|
May 23, 2025
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
Frontiers in Oncology
|
January 27, 2022
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper
Laure Fournier, Lioe-Fee de Geus-Oei, Daniele Regge, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 21, 2023
[<sup>18</sup>F]DCFPyL PET/CT versus [<sup>18</sup>F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study
Daniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, et al.
European Urology
|
September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
Daniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
The Lancet. Oncology
|
August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
Page
of 1